Character | Response | |
---|---|---|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
Media containing 1% glycine supports growth.
Fox, J. G., Chien, C. C., Dewhirst, F. E., Paster, B. J., Shen, Z., Melito, P. L., Woodward, D. L., & Rodgers, F. G. (2000). Helicobacter canadensis sp. nov. isolated from humans with diarrhea as an example of an emerging pathogen. Journal of Clinical Microbiology, 38(7), 2546–2549.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health:
Negative
Source: human faeces (diarrhoea)
|
Opt. T: 37℃
High T(℃): 42(+)
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
|
cephalothin: R(30)
|
|
|
nalidixic-acid: R(30)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
|
|
|
|